← Back to Clinical Trials
Recruiting NCT07549178

NCT07549178 Care Coordination and Passive Mobile Data Monitoring to Improve Mental Health Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07549178
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Severe Mental Illness
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2026-08-10
Primary Completion 2029-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Care Coordination Mobile

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2026-08-10 with a primary completion date of 2029-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Providing care to individuals with serious mental illness can be challenging, requiring ongoing monitoring, treatment adjustments, and coordination of various medical and social services. Rates of emergency service and hospital use are high due to unexpected social, medical, and mental health crises. Stressors and poor adherence with treatment are common and can lead to rapid worsening in symptoms, job loss, homelessness, incarceration, or suicide. Clinician visits can be infrequent. Patient-clinician contact between visits is challenging and often nonexistent. As such, illness exacerbations usually occur with no clinician awareness in real time, leaving limited opportunity to provide services. Clinicians need interventions that are capable of monitoring and quickly detecting worsening behaviors and illness, to improve care coordination, outreach, and treatment. This project studies the effectiveness of enhanced care coordination using passive mobile data monitoring and support from peer specialists, with the goal of improving outcomes and reducing the need for acute care.

Eligibility Criteria

Inclusion Criteria: * a medical record diagnosis of Serious Mental Illness (SMI) * defined as schizophrenia, schizoaffective disorder, or bipolar disorder * receipt of care at the VA site during the prior 9 months * a Care Assessment Need (CAN) score over the 75th percentile, indicating high risk for hospitalization or death in the upcoming year * ownership of a smart phone Exclusion Criteria: * none

Contact & Investigator

Central Contact

Ronald Calderon, MSW

✉ ronald.calderon@va.gov

📞 (310) 478-3711

Principal Investigator

Alexander Stehle Young, MD MSHS

PRINCIPAL INVESTIGATOR

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Frequently Asked Questions

Who can join the NCT07549178 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Severe Mental Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07549178 currently recruiting?

Yes, NCT07549178 is actively recruiting participants. Contact the research team at ronald.calderon@va.gov for enrollment information.

Where is the NCT07549178 trial being conducted?

This trial is being conducted at West Los Angeles, United States, Philadelphia, United States.

Who is sponsoring the NCT07549178 clinical trial?

NCT07549178 is sponsored by VA Office of Research and Development. The principal investigator is Alexander Stehle Young, MD MSHS at VA Greater Los Angeles Healthcare System, West Los Angeles, CA. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology